Education
About Us
Working with TipRanks
Follow Us
AbbVie (ABBV)
NYSE:ABBV
Telisotuzumab Adizutecan, Standard of Care
Non-small Cell Lung Cancer
Phase II/III
Not Yet Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Aug 28, 2025
Carboplatin, Etoposide, Atezolizumab, Lurbinectedin, Abbv-706
Small Cell Lung Cancer
Phase II/III
Not Yet Recruiting
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Aug 28, 2025
Coolsculpting Elite System
Non-Surgical Fat Reduction
Phase IV
Recruiting
A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the CoolSculpting Elite System
Aug 08, 2025
―
Dexamethasone, Daratumumab, Etentamig, Lenalidomide
Multiple Myeloma
Phase II/III
Not Yet Recruiting
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Jul 24, 2025
―
Abbv-932, Itraconazole
Healthy Volunteer
Phase I
Active Not Recruiting
A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Healthy Adult Participants
Jul 08, 2025
―
Carboplatin, Mirvetuximab Soravtansine, Bevacizumab
Ovarian Cancer
Phase II
Not Yet Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Jul 02, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does AbbVie (ABBV) have in its pipeline
ABBV is currently developing the following drugs: Telisotuzumab Adizutecan, Standard of Care, Carboplatin, Etoposide, Atezolizumab, Lurbinectedin, Abbv-706, Emraclidine. These drug candidates are in various stages of clinical development as the company works toward FDA approval.